Teflaro Powder, For Solution
Product Images NDC 0456-0400

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Teflaro (NDC 0456-0400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Teflaro 01

Chemical structure of ceftaroline fosamil, the active ingredient in Teflaro. The diagram shows the molecular arrangement including phosphate and other functional groups typical of this cephalosporin antibiotic prodrug.*

FDA Label Image

Teflaro 02

Packaging label for Teflaro (ceftaroline fosamil) for injection, 400 mg per vial powder for solution. The label shows the product name, active ingredient, strength, and form, indicating 10 single-use vials per package. It states that the product is for intravenous infusion only and that the constituted solution must be further diluted. The labeler is Allergan, Inc.*

FDA Label Image

Teflaro 03

Packaging label for Teflaro 600 mg/vial (ceftaroline fosamil) powder for injection, intravenous use. The label indicates the product contains 10 single-use vials and is manufactured by Allergan, Inc. The label includes instructions that the constituted solution must be further diluted for intravenous infusion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.